Table 3 Molecular subtypes, tumor characteristics and PET findings

Number of the patients

11 (44%)

5 (20%)

3 (12%)

6 (24%)

Age

52.09 ± 14.88

51.60 ± 13.54

53.33 ± 6.66

57.17 ± 10.80

Range: 29–79

Range: 29–63

Range: 46–59

Range: 43–75

Histological type of the carcinoma

Invasive ductal: 8 (72.7%)

Invasive ductal: 4 (80%)

Invasive ductal: 3 (100%)

Invasive ductal: 6 (100%)

Invasive lobular: 3 (27.3%)

Invasive lobular: 1 (20%)

Invasive lobular: 0 (0%)

Invasive lobular: 0 (0%)

Grade

I: 0 (0%)

I: 1 (20%)

I: 0 (0%)

I: 0 (0%)

II: 8 (72.7%)

II: 2 (40%)

II: 2 (66.7%)

II: 3 (50%)

III: 3 (27.3%)

III: 2 (40%)

III: 1 (33.3%)

III: 3 (50%)

LN

Positive: 9 (81.8%)

Positive: 3 (60%)

Positive: 2 (66.7%)

Positive: 6 (100%)

Negative: 2 (18.2%)

Negative: 2 (40%)

Negative: 1 (33.3%)

Negative: 0 (0%)

Metastasis

Positive: 5 (45.5%)

Positive: 0 (0%)

Positive: 2 (66.7%)

Positive: 2 (33.3%)

Negative: 6 (54.5%)

Negative: 5 (100%)

Negative: 1 (33.3%)

Negative: 4 (66.7%)

Ki67

33.27 ± 18.14

27.4 ± 8.88

30 ± 7

34.17 ± 9.33

Range: 20–85

Range: 12–35

Range: 25–38

Range: 25–50

Liver SUVmax

2.08 ± 0.73

2.06 ± 0.40

1.67 ± 0.15

2.27 ± 0.70

Range: 1.2–3.8

Range: 1.5–2.5

Range: 1.5–1.8

Range: 1.3–2.9

Spleen SUVmax

1.78 ± 0.54

1.92 ± 0.66

1.47 ± 0.15

2.27 ± 0.82

Range: 1–1.3

Range: 1.1–2.9

Range: 1.3–1.6

Range: 1.2–3.1